학술논문
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
Document Type
Article
Author
Source
In Blood 15 May 2005 105(10):3995-4003
Subject
Language
ISSN
0006-4971